Press "Enter" to skip to content

Roche’s lung cancer combo treatment wins FDA approval

The drug on Wednesday had also won priority review from the U.S. regulator for treating patients with untreated extensive-stage small cell lung cancer.

Original source:

Also Read:   Biocon Bengaluru unit pre-approval inspection by USFDA concludes with zero observations